NAM
HZNP

Nissay Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nissay Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,490
Closed -$2.72M – 777
2023
Q3 		$2.72M Buy
23,490
+834
+4% +$89.6K 0.02% 363
2023
Q2 		$2.33M Buy
22,656
+89
+0.4% +$9.39K 0.02% 409
2023
Q1 		$2.46M Sell
22,567
-1,164
-5% -$129K 0.02% 384
2022
Q4 		$2.7M Sell
23,731
-122
-0.5% -$10.1K 0.03% 363
2022
Q3 		$1.48M Buy
23,853
+1,201
+5% +$83.9K 0.02% 493
2022
Q2 		$1.81M Sell
22,652
-558
-2% -$52.8K 0.02% 439
2022
Q1 		$2.44M Buy
23,210
+657
+3% +$64K 0.02% 415
2021
Q4 		$2.43M Buy
22,553
+477
+2% +$52K 0.02% 426
2021
Q3 		$2.42M Buy
22,076
+913
+4% +$94.8K 0.02% 413
2021
Q2 		$1.98M Sell
21,163
-2,303
-10% -$212K 0.02% 451
2021
Q1 		$2.16M Sell
23,466
-484
-2% -$40.8K 0.02% 407
2020
Q4 		$1.75M Buy
+23,950
New +$1.78M 0.03% 435

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nissay Asset Management's HZNP Position: Q4 2023 in Review

Nissay Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 23,490 shares — an estimated $2.72M sold.

Nissay Asset Management first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $2.72M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Nissay Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Nissay Asset Management sold 23,490 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.72M.
  • Nissay Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Nissay Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.72M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nissay Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.